| Product Code: ETC9205972 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Serbia Companion Diagnostic Technologies Market Overview |
3.1 Serbia Country Macro Economic Indicators |
3.2 Serbia Companion Diagnostic Technologies Market Revenues & Volume, 2021 & 2031F |
3.3 Serbia Companion Diagnostic Technologies Market - Industry Life Cycle |
3.4 Serbia Companion Diagnostic Technologies Market - Porter's Five Forces |
3.5 Serbia Companion Diagnostic Technologies Market Revenues & Volume Share, By Indications, 2021 & 2031F |
3.6 Serbia Companion Diagnostic Technologies Market Revenues & Volume Share, By Technology, 2021 & 2031F |
4 Serbia Companion Diagnostic Technologies Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in Serbia leading to a higher demand for companion diagnostic technologies |
4.2.2 Growing emphasis on personalized medicine and targeted therapies in the healthcare sector |
4.2.3 Rising investments in research and development activities related to companion diagnostics in Serbia |
4.3 Market Restraints |
4.3.1 Regulatory challenges and uncertainties surrounding the approval and adoption of companion diagnostic technologies in the Serbian market |
4.3.2 Limited awareness and understanding among healthcare professionals and patients about the benefits of companion diagnostics |
4.3.3 High costs associated with companion diagnostic tests and technologies, impacting their accessibility and affordability in Serbia |
5 Serbia Companion Diagnostic Technologies Market Trends |
6 Serbia Companion Diagnostic Technologies Market, By Types |
6.1 Serbia Companion Diagnostic Technologies Market, By Indications |
6.1.1 Overview and Analysis |
6.1.2 Serbia Companion Diagnostic Technologies Market Revenues & Volume, By Indications, 2021- 2031F |
6.1.3 Serbia Companion Diagnostic Technologies Market Revenues & Volume, By Oncology, 2021- 2031F |
6.1.4 Serbia Companion Diagnostic Technologies Market Revenues & Volume, By Inflammation and Autoimmune diseases, 2021- 2031F |
6.1.5 Serbia Companion Diagnostic Technologies Market Revenues & Volume, By Companion diagnostics in cardiovascular diseases, 2021- 2031F |
6.1.6 Serbia Companion Diagnostic Technologies Market Revenues & Volume, By Companion diagnostics in CNS disorders, 2021- 2031F |
6.1.7 Serbia Companion Diagnostic Technologies Market Revenues & Volume, By Companion diagnostics tests in virology diseases, 2021- 2031F |
6.1.8 Serbia Companion Diagnostic Technologies Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Serbia Companion Diagnostic Technologies Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 Serbia Companion Diagnostic Technologies Market Revenues & Volume, By Immunohistochemistry, 2021- 2031F |
6.2.3 Serbia Companion Diagnostic Technologies Market Revenues & Volume, By Molecular Diagnostics, 2021- 2031F |
6.2.4 Serbia Companion Diagnostic Technologies Market Revenues & Volume, By In-situ Hybridization, 2021- 2031F |
6.2.5 Serbia Companion Diagnostic Technologies Market Revenues & Volume, By Real Time PCR, 2021- 2031F |
6.2.6 Serbia Companion Diagnostic Technologies Market Revenues & Volume, By Gene Sequencing, 2021- 2031F |
6.2.7 Serbia Companion Diagnostic Technologies Market Revenues & Volume, By Others, 2021- 2031F |
7 Serbia Companion Diagnostic Technologies Market Import-Export Trade Statistics |
7.1 Serbia Companion Diagnostic Technologies Market Export to Major Countries |
7.2 Serbia Companion Diagnostic Technologies Market Imports from Major Countries |
8 Serbia Companion Diagnostic Technologies Market Key Performance Indicators |
8.1 Adoption rate of companion diagnostic technologies by healthcare facilities in Serbia |
8.2 Number of partnerships and collaborations between diagnostic technology companies and healthcare providers in Serbia |
8.3 Rate of reimbursement for companion diagnostic tests by healthcare insurance providers in Serbia |
9 Serbia Companion Diagnostic Technologies Market - Opportunity Assessment |
9.1 Serbia Companion Diagnostic Technologies Market Opportunity Assessment, By Indications, 2021 & 2031F |
9.2 Serbia Companion Diagnostic Technologies Market Opportunity Assessment, By Technology, 2021 & 2031F |
10 Serbia Companion Diagnostic Technologies Market - Competitive Landscape |
10.1 Serbia Companion Diagnostic Technologies Market Revenue Share, By Companies, 2024 |
10.2 Serbia Companion Diagnostic Technologies Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here